[1]
“Clinical and Peripheral Blood Markers Predict Relapsed/Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant”, GMSJ, vol. 1, no. S1, Dec. 2025, Accessed: Aug. 24, 2026. [Online]. Available: http://gmscholars.com/index.php/gmsj/article/view/59